Fabtech Technologies IPO: A Comprehensive Guide for Indian Investors
The Fabtech Technologies Ltd.’s initial public offering (IPO) has opened for its final day of subscription on Wednesday, October 1. As the IPO aims to raise Rs 230.35 crore from the primary market, it’s essential for Indian investors to stay informed about the latest developments.
IPO Subscription Details
The IPO was subscribed 1.13 times as of 11:51 a.m. on Wednesday, with retail investors leading the charge. The subscription numbers are as follows:
- Institutional investors: 0.94 times or 94%
- Non-Institutional investors: 0.91 times or 91%
- Retail investors: 1.49 times
- Employee Reserved: 1.45 times
IPO Price Band and Lot Size
The price band for the IPO is set between Rs 181 and Rs 191 per share. The subscription window will be open from September 29 to October 1, with the allotment expected to be finalized on October 3. The company will transfer shares to the demat accounts of successful bidders on October 6, and refunds for non-allottees will be done on the same day.
To participate in the IPO, retail investors need to bid for a single lot size of 75 shares, requiring an investment of Rs 14,325. Small Non-Institutional Investors need to bid for 14 lots, amounting to an investment of Rs 2,00,550. Big Non-Institutional Investors can participate in the IPO by bidding for a minimum of 70 lots, leading to an investment of Rs 10,02,750.
Qualified Institutional Buyers (QIBs) and Non-Institutional Investors
QIBs will be offered a maximum of 50% of the net issue, while retail investors will be allocated a minimum of 35% of the net issue. At least 15% will be reserved for Non-Institutional Investors.
Grey Market Premium (GMP)
The latest grey market premium of Fabtech Technologies is nil as of 10:58 a.m. according to Investorgain.com. The stock’s estimated listing price is Rs 191, implying a flat listing over the IPO price of Rs 191.
Note: GMP does not represent official data and is based on speculation. GMP data sourced from InvestorGain.
Company Profile and Use of Proceeds
Fabtech Technologies is a biopharma engineering company that provides engineering solutions to pharmaceutical, biotech, and healthcare companies. The company will use the proceeds from the IPO to fund working capital requirements, pursue inorganic growth, and for general corporate purposes.
Listing Details
The shares of the company are scheduled to list on the BSE and NSE on October 7. Unistone Capital Ltd. is the book running lead manager, and Bigshare Services Ltd. is the registrar for the issue.
As the Fabtech Technologies IPO comes to a close, it’s essential for Indian investors to stay informed about the latest developments and make informed decisions. With this comprehensive guide, investors can navigate the IPO process and stay ahead of the curve.
Conclusion
In conclusion, the Fabtech Technologies IPO offers an exciting opportunity for Indian investors to participate in the growth of a biopharma engineering company. With a strong subscription response and a competitive price band, the IPO is poised for a successful listing. As the Indian stock market continues to evolve, it’s essential for investors to stay informed and adapt to the changing landscape.
